Neil James Thompson
Sales & Marketing bij POLYPEPTIDE GROUP AG
Vermogen: 37 745 $ op 31-03-2024
Profiel
Neil James Thompson is currently the Director-Global Sales & Marketing at PolyPeptide Group AG since 2022.
Previously, he worked as a Product Manager at Bachem AG from 1999 to 2003 and as a Product Manager-Peptide at Bachem (U.K.) Ltd.
from 2001 to 2003.
Mr. Thompson completed his undergraduate degree at Liverpool John Moores University in 1997.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0.00% | 31-12-2022 | 1 122 ( 0.00% ) | 37 745 $ | 31-03-2024 |
Actieve functies van Neil James Thompson
| Bedrijven | Functie | Begin |
|---|---|---|
| POLYPEPTIDE GROUP AG | Sales & Marketing | 01-01-2022 |
Eerdere bekende functies van Neil James Thompson
| Bedrijven | Functie | Einde |
|---|---|---|
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01-01-2003 |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Neil James Thompson
| Liverpool John Moores University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |
